{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:50:57Z","timestamp":1787755857036,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kankeronderzoeksfonds Limburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>\n                    <jats:bold>Abstract<\/jats:bold>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study investigates the frequency, extent and location of residual fibroglandular tissue (RFGT) on breast MRI after mastectomy and deep inferior epigastric perforator (DIEP) flap reconstruction. Possible risk factors for RFGT and the association with local breast malignancy after mastectomy (i.e. local recurrence or new primary tumour) are explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective, single-centre study included patients after mastectomy followed by DIEP flap reconstruction, who underwent breast MRI during follow-up between 2007 and 2022. Breast MRI exams were reassessed for the presence, diameter and location of RFGT. Relative risk was calculated to identify associated factors for RFGT. To investigate the possible association with malignancy after mastectomy, an explorative survival analysis was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy-three patients were included (mean age 45 years, range 21\u201368), of which 66 were diagnosed with breast cancer. RFGT was detected in twenty (27.4%) patients, with a mean diameter of 13.5\u2009mm (range 6\u201331), most frequently located in the upper outer quadrant of the breast. Tumour grade 3 seemed to be associated with increased risk of RFGT (RR\u2009=\u20092.7, 95% CI: 1.1\u20136.6,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.050). After a median follow-up time of 110.0 months (range 14\u2013354), malignancy after mastectomy had occurred in thirteen patients; this risk was non-significantly higher in patients with RFGT (HR\u2009=\u20092.3, 95% CI: 0.769\u20136.827,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.137).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RFGT is frequently detected on breast MRI after mastectomy and DIEP flap reconstruction. A baseline postoperative breast MRI exam could possibly be relevant to detect RFGT. The potential association with higher risk of malignancies after mastectomy warrants further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"simple\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Question<\/jats:bold>\n                            research on RFGT detection after autologous reconstruction remains limited; therefore, this study investigates RFGT extent, location, risk factors, and association with malignancy.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Findings<\/jats:bold>\n                            RFGT could be detected on breast MRI in 27.4% of patients after DIEP\u00a0flap reconstruction and might potentially be associated with an increased post-mastectomy malignancy risk.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Critical relevance<\/jats:bold>\n                            RFGT can frequently be detected on breast MRI following mastectomy and DIEP\u00a0flap reconstruction and might be relevant for oncological safety. Future research is needed to validate this and assess the value of a postoperative baseline breast MRI for RFGT detection.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02382-6","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:50:24Z","timestamp":1787748624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of residual fibroglandular tissue on breast MRI and associated factors in women treated with mastectomy and DIEP flap breast reconstruction"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4252-3226","authenticated-orcid":false,"given":"Nieke N. P. M.","family":"Smeins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep A. F.","family":"van Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther M.","family":"Heuts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke B.","family":"Houwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty J.","family":"Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania M. H.","family":"Tuinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiemo J. A.","family":"van Nijnatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2382_CR1","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","volume":"24","author":"BA Heemskerk-Gerritsen","year":"2013","unstructured":"Heemskerk-Gerritsen BA, Menke-Pluijmers MB, Jager A et al (2013) Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis. Ann Oncol 24:2029\u20132035","journal-title":"Ann Oncol"},{"key":"2382_CR2","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633\u20131637","journal-title":"J Natl Cancer Inst"},{"key":"2382_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10549-020-05966-y","volume":"185","author":"JM Simons","year":"2021","unstructured":"Simons JM, Jacobs JG, Roijers JP et al (2021) Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study. Breast Cancer Res Treat 185:441\u2013451","journal-title":"Breast Cancer Res Treat"},{"key":"2382_CR4","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.ejca.2012.03.008","volume":"48","author":"CA Garcia-Etienne","year":"2012","unstructured":"Garcia-Etienne CA, Tomatis M, Heil J et al (2012) Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. Eur J Cancer 48:1947\u20131956","journal-title":"Eur J Cancer"},{"key":"2382_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2018.02.003","volume":"39","author":"A Fancellu","year":"2018","unstructured":"Fancellu A, Sanna V, Cottu P et al (2018) Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients. Breast 39:1\u20137","journal-title":"Breast"},{"key":"2382_CR6","doi-asserted-by":"publisher","first-page":"e2251348","DOI":"10.1001\/jamanetworkopen.2022.51348","volume":"6","author":"M Fefferman","year":"2023","unstructured":"Fefferman M, Nicholson K, Kuchta K, Pesce C, Kopkash K, Yao K (2023) Rates of bilateral mastectomy in patients with early-stage breast cancer. JAMA Netw Open 6:e2251348","journal-title":"JAMA Netw Open"},{"key":"2382_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","volume":"150","author":"KL Kummerow","year":"2015","unstructured":"Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA (2015) Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg 150:9\u201316","journal-title":"JAMA Surg"},{"key":"2382_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/ajm.AJM_21_18","volume":"8","author":"RK Alaofi","year":"2018","unstructured":"Alaofi RK, Nassif MO, Al-Hajeili MR (2018) Prophylactic mastectomy for the prevention of breast cancer: review of the literature. Avicenna J Med 8:67\u201377","journal-title":"Avicenna J Med"},{"key":"2382_CR9","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/ijc.23340","volume":"122","author":"KA Metcalfe","year":"2008","unstructured":"Metcalfe KA, Birenbaum-Carmeli D, Lubinski J et al (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122:2017\u20132022","journal-title":"Int J Cancer"},{"key":"2382_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/tbj.13293","volume":"25","author":"SP Lazow","year":"2019","unstructured":"Lazow SP, Riba L, Alapati A, James TA (2019) Comparison of breast-conserving therapy vs mastectomy in women under age 40: national trends and potential survival implications. Breast J 25:578\u2013584","journal-title":"Breast J"},{"key":"2382_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1524-4741.2012.01245.x","volume":"18","author":"AE Dragun","year":"2012","unstructured":"Dragun AE, Huang B, Tucker TC, Spanos WJ (2012) Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Breast J 18:318\u2013325","journal-title":"Breast J"},{"key":"2382_CR12","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1245\/s10434-013-2982-x","volume":"20","author":"CA Garcia-Etienne","year":"2013","unstructured":"Garcia-Etienne CA, Tomatis M, Heil J et al (2013) Fluctuating mastectomy rates across time and geography. Ann Surg Oncol 20:2114\u20132116","journal-title":"Ann Surg Oncol"},{"key":"2382_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/SAP.0000000000003764","volume":"92","author":"JK Shah","year":"2024","unstructured":"Shah JK, Amakiri UO, Cevallos P et al (2024) Updated trends and outcomes in autologous breast reconstruction in the United States, 2016\u20132019. Ann Plast Surg 92:e1\u2013e13","journal-title":"Ann Plast Surg"},{"key":"2382_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/SAP.0000000000002664","volume":"87","author":"H Masoomi","year":"2021","unstructured":"Masoomi H, Hanson SE, Clemens MW, Mericli AF (2021) Autologous breast reconstruction trends in the United States: using the Nationwide Inpatient Sample database. Ann Plast Surg 87:242\u2013247","journal-title":"Ann Plast Surg"},{"key":"2382_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bjps.2010.04.030","volume":"64","author":"TH Damen","year":"2011","unstructured":"Damen TH, de Bekker-Grob EW, Mureau MA et al (2011) Patients\u2019 preferences for breast reconstruction: a discrete choice experiment. J Plast Reconstr Aesthet Surg 64:75\u201383","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2382_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0748-7983(03)00079-9","volume":"29","author":"SE Hall","year":"2003","unstructured":"Hall SE, Holman CD (2003) Inequalities in breast cancer reconstructive surgery according to social and locational status in Western Australia. Eur J Surg Oncol 29:519\u2013525","journal-title":"Eur J Surg Oncol"},{"key":"2382_CR17","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00520-018-4470-0","volume":"27","author":"PS Soon","year":"2019","unstructured":"Soon PS, Ruban S, Mo HTJ et al (2019) Understanding patient choices regarding breast reconstruction after mastectomy for breast cancer. Support Care Cancer 27:2135\u20132142","journal-title":"Support Care Cancer"},{"key":"2382_CR18","doi-asserted-by":"crossref","unstructured":"Roy N, Downes MH, Ibelli T et al (2024) The psychological impacts of post-mastectomy breast reconstruction: a systematic review. Ann Breast Surg 8:19","DOI":"10.21037\/abs-23-33"},{"key":"2382_CR19","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1056\/NEJMct0802899","volume":"359","author":"PG Cordeiro","year":"2008","unstructured":"Cordeiro PG (2008) Breast reconstruction after surgery for breast cancer. N Engl J Med 359:1590\u20131601","journal-title":"N Engl J Med"},{"key":"2382_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12282-020-01076-1","volume":"27","author":"S Zehra","year":"2020","unstructured":"Zehra S, Doyle F, Barry M, Walsh S, Kell MR (2020) Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis. Breast Cancer 27:534\u2013566","journal-title":"Breast Cancer"},{"key":"2382_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.815498","volume":"12","author":"M Shiraishi","year":"2022","unstructured":"Shiraishi M, Sowa Y, Tsuge I, Kodama T, Inafuku N, Morimoto N (2022) Long-term patient satisfaction and quality of life following breast reconstruction using the BREAST-Q: a prospective cohort study. Front Oncol 12:815498","journal-title":"Front Oncol"},{"key":"2382_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/s-0043-1767788","volume":"50","author":"NE Speck","year":"2023","unstructured":"Speck NE, Grufman V, Farhadi J (2023) Trends and innovations in autologous breast reconstruction. Arch Plast Surg 50:240\u2013247","journal-title":"Arch Plast Surg"},{"key":"2382_CR23","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.21037\/gs-23-288","volume":"12","author":"M Hamdi","year":"2023","unstructured":"Hamdi M, Kapila AK, Waked K (2023) Current status of autologous breast reconstruction in Europe: how to reduce donor site morbidity. Gland Surg 12:1760\u20131773","journal-title":"Gland Surg"},{"key":"2382_CR24","doi-asserted-by":"publisher","first-page":"e3433","DOI":"10.1097\/GOX.0000000000003433","volume":"9","author":"R Garza 3rd","year":"2021","unstructured":"Garza 3rd R, Ochoa O, Chrysopoulo M (2021) Post-mastectomy breast reconstruction with autologous tissue: current methods and techniques. Plast Reconstr Surg Glob Open 9:e3433","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2382_CR25","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.21037\/gs-21-15","volume":"10","author":"JH Joo","year":"2021","unstructured":"Joo JH, Ki Y, Kim W et al (2021) Pattern of local recurrence after mastectomy and reconstruction in breast cancer patients: a systematic review. Gland Surg 10:2037\u20132046","journal-title":"Gland Surg"},{"key":"2382_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jamcollsurg.2006.06.015","volume":"203","author":"CL Buchanan","year":"2006","unstructured":"Buchanan CL, Dorn PL, Fey J et al (2006) Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg 203:469\u2013474","journal-title":"J Am Coll Surg"},{"key":"2382_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-020-05774-4","volume":"183","author":"O Kaidar-Person","year":"2020","unstructured":"Kaidar-Person O, Poortmans P, Offersen BV et al (2020) Spatial location of local recurrences after mastectomy: a systematic review. Breast Cancer Res Treat 183:263\u2013273","journal-title":"Breast Cancer Res Treat"},{"key":"2382_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"Rebbeck","year":"2004","unstructured":"Rebbeck, Friebel T TR, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055\u20131062","journal-title":"J Clin Oncol"},{"key":"2382_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"2382_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/SLA.0b013e3181c3c36d","volume":"251","author":"R Kaas","year":"2010","unstructured":"Kaas R, Verhoef S, Wesseling J et al (2010) Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer. Ann Surg 251:488\u2013492","journal-title":"Ann Surg"},{"key":"2382_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ejso.2016.04.055","volume":"42","author":"S Al-Himdani","year":"2016","unstructured":"Al-Himdani S, Timbrell S, Tan KT, Morris J, Bundred NJ (2016) Prediction of margin involvement and local recurrence after skin-sparing and simple mastectomy. Eur J Surg Oncol 42:935\u2013941","journal-title":"Eur J Surg Oncol"},{"key":"2382_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejrad.2018.04.028","volume":"104","author":"R Woitek","year":"2018","unstructured":"Woitek R, Pfeiler G, Farr A et al (2018) MRI-based quantification of residual fibroglandular tissue of the breast after conservative mastectomies. Eur J Radiol 104:1\u20137","journal-title":"Eur J Radiol"},{"key":"2382_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.clinimag.2014.12.014","volume":"39","author":"D Zippel","year":"2015","unstructured":"Zippel D, Tsehmaister-Abitbol V, Rundstein A et al (2015) Magnetic resonance imaging (MRI) evaluation of residual breast tissue following mastectomy and reconstruction with silicone implants. Clin Imaging 39:408\u2013411","journal-title":"Clin Imaging"},{"key":"2382_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijrobp.2018.05.023","volume":"102","author":"DG Giannotti","year":"2018","unstructured":"Giannotti DG, Hanna SA, Cerri GG, Barbosa Bevilacqua JL (2018) Analysis of skin flap thickness and residual breast tissue after mastectomy. Int J Radiat Oncol Biol Phys 102:82\u201391","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2382_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","volume":"34","author":"C Sessa","year":"2023","unstructured":"Sessa C, Balma\u00f1a J, Bober SL et al (2023) Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline. Ann Oncol 34:33\u201347","journal-title":"Ann Oncol"},{"key":"2382_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","volume":"35","author":"S Loibl","year":"2024","unstructured":"Loibl S, Andr\u00e9 F, Bachelot T et al (2024) Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 35:159\u2013182","journal-title":"Ann Oncol"},{"key":"2382_CR37","unstructured":"(NCCN\u00ae). NCCN (2024) NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae): breast cancer. Version 6.2024. Available via NCCN. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1419"},{"key":"2382_CR38","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1245\/s10434-020-08516-4","volume":"27","author":"O Kaidar-Person","year":"2020","unstructured":"Kaidar-Person O, Boersma LJ, Poortmans P et al (2020) Residual glandular breast tissue after mastectomy: a systematic review. Ann Surg Oncol 27:2288\u20132296","journal-title":"Ann Surg Oncol"},{"key":"2382_CR39","volume-title":"Applied","author":"DW Hosmer","year":"2004","unstructured":"Hosmer DW, Lemeshow S (2004) Logistic regression. Applied. Wiley"},{"key":"2382_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric Estimation from Incomplete Observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"2382_CR41","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163\u2013170","journal-title":"Cancer Chemother Rep"},{"key":"2382_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables. J R Stat Soc B (Methodological) 34:187\u2013220","journal-title":"J R Stat Soc B (Methodological)"},{"key":"2382_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-09315-1","volume":"15","author":"MO Kulturoglu","year":"2025","unstructured":"Kulturoglu MO, Aydin F, Sagdic MF et al (2025) The impact of changes in breast density over time on breast cancer risk. Sci Rep 15:23900","journal-title":"Sci Rep"},{"key":"2382_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mri.2010.07.009","volume":"29","author":"JH Chen","year":"2011","unstructured":"Chen JH, Chang YC, Chang D et al (2011) Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study. Magn Reson Imaging 29:91\u201398","journal-title":"Magn Reson Imaging"},{"key":"2382_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10764-y","volume":"23","author":"C Deutschmann","year":"2023","unstructured":"Deutschmann C, Singer CF, Gschwantler-Kaulich D et al (2023) Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer. BMC Cancer 23:281","journal-title":"BMC Cancer"},{"key":"2382_CR46","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1245\/s10434-019-07259-1","volume":"26","author":"B Papassotiropoulos","year":"2019","unstructured":"Papassotiropoulos B, G\u00fcth U, Chiesa F et al (2019) Prospective evaluation of residual breast tissue after skin- or nipple-sparing mastectomy: results of the SKINI-trial. Ann Surg Oncol 26:1254\u20131262","journal-title":"Ann Surg Oncol"},{"key":"2382_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bjps.2003.11.030","volume":"57","author":"GP Gui","year":"2004","unstructured":"Gui GP, Behranwala KA, Abdullah N et al (2004) The inframammary fold: contents, clinical significance and implications for immediate breast reconstruction. Br J Plast Surg 57:146\u2013149","journal-title":"Br J Plast Surg"},{"key":"2382_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00006534-199609000-00012","volume":"98","author":"GW Carlson","year":"1996","unstructured":"Carlson GW, Grossl N, Lewis MM, Temple JR, Styblo TM (1996) Preservation of the inframammary fold: What are we leaving behind? Plast Reconstr Surg 98:447\u2013450","journal-title":"Plast Reconstr Surg"},{"key":"2382_CR49","first-page":"17","volume":"172","author":"SS Kroll","year":"1991","unstructured":"Kroll SS, Ames F, Singletary SE, Schusterman MA (1991) The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. Surg Gynecol Obstet 172:17\u201320","journal-title":"Surg Gynecol Obstet"},{"key":"2382_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108607","volume":"50","author":"O Kaidar-Person","year":"2024","unstructured":"Kaidar-Person O, Sklair-Levy M, Anaby D et al (2024) Residual breast tissue after mastectomy and reconstruction: a substudy of the spatial location of breast cancer local recurrence after mastectomy (SECRET) project. Eur J Surg Oncol 50:108607","journal-title":"Eur J Surg Oncol"},{"key":"2382_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12491-4","volume":"24","author":"D Christine","year":"2024","unstructured":"Christine D, Christian SF, Ricarda K et al (2024) Risk factors for residual fibroglandular breast tissue following a mastectomy - an overview and retrospective cohort study. BMC Cancer 24:856","journal-title":"BMC Cancer"},{"key":"2382_CR52","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s11845-022-02926-x","volume":"191","author":"D Courtney","year":"2022","unstructured":"Courtney D, Davey MG, Moloney BM et al (2022) Breast cancer recurrence: factors impacting occurrence and survival. Irish J Med Sci 191:2501\u20132510","journal-title":"Irish J Med Sci"},{"key":"2382_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.suronc.2019.04.009","volume":"29","author":"O Grinstein","year":"2019","unstructured":"Grinstein O, Krug B, Hellmic M et al (2019) Residual glandular tissue (RGT) in BRCA1\/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies. Surg Oncol 29:126\u2013133","journal-title":"Surg Oncol"},{"key":"2382_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07594-7","volume":"20","author":"J Wang","year":"2020","unstructured":"Wang J, Tang Y, Jing H et al (2020) Risk stratification for prediction of locoregional recurrence in patients with pathologic T1-2N0 breast cancer after mastectomy. BMC Cancer 20:1132","journal-title":"BMC Cancer"},{"key":"2382_CR55","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/00006534-199012000-00012","volume":"86","author":"N Handel","year":"1990","unstructured":"Handel N, Silverstein MJ, Waisman E, Waisman JR (1990) Reasons why mastectomy patients do not have breast reconstruction. Plast Reconstr Surg 86:1118\u20131122","journal-title":"Plast Reconstr Surg"},{"key":"2382_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107031","volume":"49","author":"S Mohrmann","year":"2023","unstructured":"Mohrmann S, Kolberg L, J\u00e4ger B et al (2023) Impact of surgical variables on residual glandular tissue in risk-reducing mastectomies: results of a retrospective monocentric study from a Centre of the German Consortium for hereditary breast and ovarian cancer. Eur J Surg Oncol 49:107031","journal-title":"Eur J Surg Oncol"},{"key":"2382_CR57","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/cancers15030829","volume":"15","author":"F Dietzel","year":"2023","unstructured":"Dietzel F, Kolberg L, Vesper AS et al (2023) Factors influencing residual glandular breast tissue after risk-reducing mastectomy in genetically predisposed individuals detected by MRI mammography. Cancers (Basel) 15:829","journal-title":"Cancers (Basel)"},{"key":"2382_CR58","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1245\/ASO.2005.11.027","volume":"12","author":"RZ Torresan","year":"2005","unstructured":"Torresan RZ, dos Santos CC, Okamura H, Alvarenga M (2005) Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol 12:1037\u20131044","journal-title":"Ann Surg Oncol"},{"key":"2382_CR59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.21873\/cdp.10369","volume":"4","author":"H Fritsch","year":"2024","unstructured":"Fritsch H, Tumeltshammer R, Hachenberg J et al (2024) Comparison of the preoperative MRI evaluation of glandular tissue in subcutaneous mastectomy and its influence on the implant volume. Cancer Diagn Progn 4:599\u2013604","journal-title":"Cancer Diagn Progn"},{"key":"2382_CR60","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10549-024-07425-4","volume":"208","author":"O Kaidar-Person","year":"2024","unstructured":"Kaidar-Person O, Faermann R, Polikar D et al (2024) A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstruction. Breast Cancer Res Treat 208:359\u2013367","journal-title":"Breast Cancer Res Treat"},{"key":"2382_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejrad.2019.02.033","volume":"114","author":"M Dietzel","year":"2019","unstructured":"Dietzel M, Wenkel E, Hammon M et al (2019) Does higher field strength translate into better diagnostic accuracy? A prospective comparison of breast MRI at 3 and 1.5 Tesla. Eur J Radiol 114:51\u201356","journal-title":"Eur J Radiol"},{"key":"2382_CR62","unstructured":"Rothman KJ (1986) Modern epidemiology. Little, Brown and Company, Boston\/Toronto"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02382-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02382-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02382-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:02:14Z","timestamp":1787752934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02382-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02382-6","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Board approval was obtained from the METC azM\/UM on March 3, 2022 (reference number: METC 2022-3122). Written informed consent was waived by the Institutional Review Board.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.J.A.v.N.: Speaker honoraria, participation in medical advisory board meetings and institutional grant support from Bayer and GE Healthcare. Advisory board for Screenpoint Medical. Other authors of this manuscript declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"208"}}